- Home
- RARE vs KEN Comparison
RARE vs KEN Comparison
Compare RARE & KEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RARE | KEN |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.7B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | RARE | KEN |
|---|---|---|
| Price | $34.13 | $65.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $85.20 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 12.5K |
| Earning Date | 02-12-2026 | 12-03-2025 |
| Dividend Yield | N/A | ★ 7.42% |
| EPS Growth | N/A | ★ 177.70 |
| EPS | N/A | ★ 8.96 |
| Revenue | $630,598,000.00 | ★ $803,304,000.00 |
| Revenue This Year | $19.09 | N/A |
| Revenue Next Year | $20.62 | N/A |
| P/E Ratio | ★ N/A | $7.07 |
| Revenue Growth | ★ 20.63 | 8.15 |
| 52 Week Low | $25.81 | $27.10 |
| 52 Week High | $46.50 | $64.85 |
Technical Indicators
Market Signals| Indicator | RARE | KEN |
|---|---|---|
| Relative Strength Index (RSI) | 49.54 | 76.52 |
| Support Level | $32.64 | $60.35 |
| Resistance Level | $35.12 | $62.68 |
| Average True Range (ATR) | 1.44 | 1.24 |
| MACD | -0.27 | 0.11 |
| Stochastic Oscillator | 22.07 | 87.76 |
Price Performance
Historical ComparisonAbout RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About KEN Kenon Holdings Ltd.
Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.